HB Wealth Management LLC Purchases 2,614 Shares of Waters Corporation $WAT

HB Wealth Management LLC grew its holdings in shares of Waters Corporation (NYSE:WAT) by 165.0% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 4,198 shares of the medical instruments supplier’s stock after buying an additional 2,614 shares during the quarter. HB Wealth Management LLC’s holdings in Waters were worth $1,250,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Brighton Jones LLC grew its position in Waters by 112.9% in the 4th quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier’s stock valued at $471,000 after acquiring an additional 673 shares during the last quarter. Integrated Wealth Concepts LLC lifted its position in shares of Waters by 2.9% during the first quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier’s stock worth $386,000 after purchasing an additional 30 shares during the last quarter. Goldman Sachs Group Inc. boosted its stake in shares of Waters by 3.6% during the first quarter. Goldman Sachs Group Inc. now owns 200,051 shares of the medical instruments supplier’s stock valued at $73,733,000 after purchasing an additional 6,976 shares during the period. Empowered Funds LLC grew its holdings in shares of Waters by 16.6% in the first quarter. Empowered Funds LLC now owns 1,126 shares of the medical instruments supplier’s stock worth $415,000 after purchasing an additional 160 shares during the last quarter. Finally, Sivia Capital Partners LLC bought a new position in shares of Waters in the second quarter worth about $232,000. 94.01% of the stock is currently owned by hedge funds and other institutional investors.

Waters Price Performance

NYSE WAT opened at $374.94 on Wednesday. The company has a market cap of $36.82 billion, a PE ratio of 47.64, a P/E/G ratio of 2.29 and a beta of 1.20. The firm’s 50 day moving average price is $354.18 and its 200-day moving average price is $346.74. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.13 and a current ratio of 1.79. Waters Corporation has a 52-week low of $275.05 and a 52-week high of $414.15.

Waters (NYSE:WAT) last posted its earnings results on Tuesday, May 5th. The medical instruments supplier reported $2.70 earnings per share for the quarter, topping analysts’ consensus estimates of $2.31 by $0.39. The company had revenue of $1.27 billion during the quarter, compared to analyst estimates of $1.20 billion. Waters had a return on equity of 15.60% and a net margin of 11.91%.Waters’s revenue was up 91.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.25 earnings per share. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. Sell-side analysts forecast that Waters Corporation will post 14.51 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on WAT. Piper Sandler started coverage on shares of Waters in a report on Thursday, June 11th. They set a “neutral” rating and a $400.00 price objective for the company. Robert W. Baird set a $387.00 target price on shares of Waters in a research report on Wednesday, May 6th. TD Cowen lifted their price target on shares of Waters from $345.00 to $385.00 and gave the company a “hold” rating in a research note on Wednesday, May 6th. The Goldman Sachs Group upgraded Waters to a “strong-buy” rating in a report on Wednesday, April 1st. Finally, HSBC raised their price objective on Waters from $415.00 to $435.00 and gave the stock a “buy” rating in a report on Wednesday, June 3rd. Four analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $399.84.

Waters Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.